Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics

No abstract is available for this paper.

• Publication year

  2008

• Venue

  American Journal of Medical Genetics. Part C, Seminars in Medical Genetics

• Publication date

  2008-05-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/ajmg.c.30172PMID 18412102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emotion circuits in the brain.

  2009cited by this paper
• Increased amygdala and insula activation during emotion processing in anxiety-prone subjects.

  2007cited by this paper
• N-acetyl cysteine in the treatment of grooming disorders.

  2007cited by this paper
• A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.

  2007cited by this paper
• Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD).

  2007cited by this paper
• D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

  2007cited by this paper
• Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice.

  2007influential reference
• Treating DSM-IV depression with atypical features.

  2007cited by this paper
• Is cocaine desire reduced by N-acetylcysteine?

  2007cited by this paper
• Sensitivity to intranasal oxytocin in adult men with early parental separation.

  2007cited by this paper
• The global burden of anxiety and mood disorders: putting the European Study of the Epidemiology of Mental Disorders (ESEMeD) findings into perspective.

  2007cited by this paper
• Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic

  2007cited by this paper
• D-cycloserine does not enhance exposure–response prevention therapy in obsessive–compulsive disorder

  2007cited by this paper
• Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.

  2007cited by this paper
• A history of the concept of atypical depression.

  2007cited by this paper
• If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans.

  2007influential reference
• Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys.

  2007cited by this paper
• An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study.

  2007cited by this paper
• Persistent disruption of a traumatic memory by postretrieval inactivation of glucocorticoid receptors in the amygdala.

  2007cited by this paper
• The serotonergic system and anxiety

  2007cited by this paper
• Modulation of Fear and Anxiety by the Endogenous Cannabinoid System

  2007cited by this paper
• Symptom provocation in specific phobia affects the substance P neurokinin-1 receptor system.

  2007cited by this paper
• N‐acetylcysteine attenuates the decline in muscle Na+,K+‐pump activity and delays fatigue during prolonged exercise in humans

  2006cited by this paper
• Advances in Understanding Neuroendocrine Alterations in PTSD and Their Therapeutic Implications

  2006cited by this paper
• Metabotropic Glutamate Receptor Subtype 7 Ablation Causes Dysregulation of the HPA Axis and Increases Hippocampal BDNF Protein Levels: Implications for Stress-Related Psychiatric Disorders

  2006cited by this paper
• Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder.

  2006cited by this paper
• Elevated cerebrospinal fluid substance P concentrations in posttraumatic stress disorder and major depression

  2006cited by this paper
• Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depression.

  2006cited by this paper
• Brain mechanisms of fear extinction: historical perspectives on the contribution of prefrontal cortex.

  2006cited by this paper
• Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease

  2006cited by this paper
• Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.

  2006influential reference
• Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping.

  2006cited by this paper
• Prefrontal mechanisms in extinction of conditioned fear.

  2006cited by this paper
• Effects of D-cycloserine on extinction: translation from preclinical to clinical work.

  2006cited by this paper
• Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future.

  2006cited by this paper
• An insular view of anxiety.

  2006cited by this paper
• Neural systems involved in fear and anxiety measured with fear-potentiated startle.

  2006cited by this paper
• Fear is fast in phobic individuals: amygdala activation in response to fear-relevant stimuli.

  2006cited by this paper
• Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

  2006cited by this paper
• Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

  2006cited by this paper
• The role of substance P in stress and anxiety responses

  2006cited by this paper
• Combining pharmacotherapy with cognitive behavioral therapy: traditional and new approaches.

  2006cited by this paper
• Brain activation of spider phobics towards disorder-relevant, generally disgust- and fear-inducing pictures.

  2005cited by this paper
• Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.

  2005cited by this paper
• Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity

  2005cited by this paper
• Orexin, drugs and motivated behaviors

  2005cited by this paper
• The midbrain periaqueductal gray and fear extinction: opioid receptor subtype and roles of cyclic AMP, protein kinase A, and mitogen-activated protein kinase.

  2005cited by this paper
• Is there a common molecular pathway for addiction?

  2005cited by this paper
• Contributions of the amygdala to emotion processing: from animal models to human behavior.

  2005cited by this paper
• Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla

  2005cited by this paper
• One for all or one for one: does co-transmission unify the concept of a brain galanin "system" or clarify any consistent role in anxiety?

  2005cited by this paper
• Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice

  2005influential reference
• A role for lateral hypothalamic orexin neurons in reward seeking

  2005cited by this paper
• Anxiety disorders: noradrenergic neurotransmission.

  2005cited by this paper
• Glutamate Modulation in Mood and Anxiety Disorders: Toward a Rational Pharmacology?

  2005cited by this paper
• Metabotropic glutamate receptors as novel targets for anxiety and stress disorders

  2005influential reference
• Cystine/Glutamate Exchange Regulates Metabotropic Glutamate Receptor Presynaptic Inhibition of Excitatory Transmission and Vulnerability to Cocaine Seeking

  2005cited by this paper
• Open-label trial of riluzole in generalized anxiety disorder.

  2005cited by this paper
• Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.

  2005cited by this paper
• The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder.

  2005cited by this paper
• Facilitation of fear extinction by midbrain periaqueductal gray infusions of RB101(S), an inhibitor of enkephalin-degrading enzymes.

  2005cited by this paper
• Effects of N‐acetylcysteine on glutathione oxidation and fatigue during handgrip exercise

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• ects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats

  2005cited by this paper
• Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters

  2005cited by this paper
• Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala

  2005cited by this paper
• Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

  2005cited by this paper
• Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior.

  2005influential reference
• Enhancing Cannabinoid Neurotransmission Augments the Extinction of Conditioned Fear

  2005cited by this paper
• N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder

  2005cited by this paper
• Oxytocin increases trust in humans

  2005cited by this paper
• Effects of citalopram on worry and brain activation in patients with generalized anxiety disorder.

  2004influential reference
• Neuroendocrine basis of social recognition.

  2004cited by this paper
• Neural correlates of speech anticipatory anxiety in generalized social phobia

  2004cited by this paper
• Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala.

  2004cited by this paper
• Neural systems supporting interoceptive awareness

  2004cited by this paper
• The Behavioral Profile of the Potent and Selective mGlu5 Receptor Antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in Rodent Models of Anxiety

  2004cited by this paper
• The therapeutic potential of CRF1 antagonists for anxiety

  2004cited by this paper
• Adrenergic transmission facilitates extinction of conditional fear in mice.

  2004cited by this paper
• Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

  2004cited by this paper
• Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response.

  2004cited by this paper
• Adaptive and maladaptive psychobiological responses to severe psychological stress: implications for the discovery of novel pharmacotherapy.

  2004cited by this paper
• Metyrapone tests in patients with panic disorder.

  2004cited by this paper
• Anxiolytic-Like Effects of the Corticotropin-Releasing Factor1 (CRF1) Antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] Administered Acutely or Chronically at Doses Occupying Central CRF1 Receptors in Rats

  2004cited by this paper
• Cardiac Sympathetic Nerve Biology and Brain Monoamine Turnover in Panic Disorder

  2004cited by this paper
• Glutamate and anxiety.

  2004cited by this paper
• Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.

  2004cited by this paper
• Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression.

  2004cited by this paper
• [Pharmacotherapy for anxiety disorders].

  2004cited by this paper
• du CRSN : le point sur la dépression , première partie Impact of substance P receptor antagonism on the serotonin and norepinephrine systems : relevance to the antidepressant / anxiolytic response

  2004cited by this paper
• Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress.

  2004influential reference
• Amygdala and insular responses to emotionally valenced human faces in small animal specific phobia.

  2003cited by this paper
• The human amygdala and the emotional evaluation of sensory stimuli.

  2003cited by this paper
• Cortisol variation in humans affects memory for emotionally laden and neutral information.

  2003cited by this paper
• Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma.

  2003cited by this paper
• Epinephrine enhancement of human memory consolidation: interaction with arousal at encoding.

  2003cited by this paper
• Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition.

  2003cited by this paper
• Corticotropin-releasing hormone modulators and depression.

  2003cited by this paper
• Trauma exposure rather than posttraumatic stress disorder is associated with reduced baseline plasma neuropeptide-Y levels.

  2003cited by this paper
• Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects.

  2003cited by this paper

• Holistic approaches in the treatment of generalized anxiety disorder in adolescents: A focus on homoeopathy and therapy

  2025cites this paper
• Evaluation of anxiolytic effect of aqueous extract of Garcinia indica seeds using open field test

  2025cites this paper
• Anxiolytic-like Effect Characterization of Essential Oil from Local Lavender Cultivation

  2025cites this paper
• Brain TRPV1 channel-mediated calcium influx: the immunomodulatory pathway of acupuncture in neuroinflammation

  2025cites this paper
• Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders

  2023cites this paper
• The Challenging Role of Flavonoids as a Potential Phytochemical to Treat Anxiety

  2023cites this paper
• Role of the GRP/GRPR System in Regulating Brain Functions.

  2023cites this paper
• Hypothalamus and Post-Traumatic Stress Disorder: A Review

  2023cites this paper
• Decreased medial prefrontal cortex activity related to impaired novel object preference task performance following GALR2 and Y1R agonists intranasal infusion.

  2023cites this paper
• Clinically significant anxiety as a risk factor for Alzheimer's disease: Results from a 10‐year follow‐up community study

  2023cites this paper
• Association between anxiety symptoms and Alzheimer’s disease biomarkers in cognitively healthy adults: A systematic review and meta‐analysis

  2023cites this paper
• Protective Role and Functional Engineering of Neuropeptides in Depression and Anxiety: An Overview

  2023cites this paper
• Integrated mental health treatment guidelines for prescribers in intellectual and developmental disabilities

  2022cites this paper
• Don't Be Afraid, Try to Meditate- Potential Effects on Neural Activity and Connectivity of Psilocybin-Assisted Mindfulness-Based Intervention for Social Anxiety Disorder: A systematic review.

  2022cites this paper
• Repeated acetaminophen administration damaged hippocampal tissue but did not affect prefrontal cortex or anxiety behaviors.

  2022cites this paper
• The Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) System of the Central Amygdala Mediates the Detrimental Effects of Chronic Social Defeat Stress in Rats

  2022cites this paper
• Critical Aspects of Neurodevelopment.

  2021cites this paper
• The Periaqueductal Gray and Its Extended Participation in Drug Addiction Phenomena

  2021cites this paper
• Neuropharmacological Activity of the New Piperazine Derivative 2-(4-((1- Phenyl-1H-Pyrazol-4-yl)Methyl)Piperazin-1-yl)Ethyl Acetate is Modulated by Serotonergic and GABAergic Pathways.

  2021cites this paper
• Gender-related romantic attachment and serum oxytocin level difference in adult patients with obsessive compulsive disorder

  2021cites this paper
• Evaluation of anxiolytic and anti-depressant activity of Neolamarckia cadamba in mice

  2021cites this paper
• Current Understanding of the Neurobiology of Agitation

  2020cites this paper
• Training the anxious brain: using fMRI‐based neurofeedback to change brain activity in adolescence

  2020cites this paper
• Bases fisiológicas e medicamentosas do transtorno da ansiedade

  2020cites this paper
• Different effects of chronic social defeat on social behavior and the brain CRF system in adult male C57 mice with different susceptibilities.

  2020cites this paper
• Behavioral and Psychological Symptoms in Vascular Cognitive Impairment

  2020cites this paper
• L1-79 and the Role of Catecholamines in Autism

  2020cites this paper
• Change in neural response during emotion regulation is associated with symptom reduction in cognitive behavioral therapy for anxiety disorders.

  2020cites this paper
• [Anxiety in the elderly].

  2019cites this paper
• Stress, Corticosterone, and Hippocampal Plasticity

  2019cites this paper
• Comparison of anxiolytic activity of Garcinia indica (Kokum) with diazepam in rats using elevated plus maze test

  2019cites this paper
• Effect of Prenatal Stress on Offspring's Learning, Memory and Coping Strategies

  2019cites this paper
• Updating the evidence for an association between anxiety and risk of Alzheimer's disease: A meta-analysis of prospective cohort studies.

  2019cites this paper
• Evidence that hydrogen peroxide, a component of oxidative stress, induces high‐anxiety‐related behaviour in mice

  2019cites this paper
• Benzodiazepines Dependence: Addiction to Legally Prescribed Substances

  2019cites this paper
• Role of the PACAP system of the extended amygdala in the acoustic startle response in rats.

  2019cites this paper
• Anxiety Disorders: From Bench to Bedside and Beyond

  2018cites this paper
• A critical inquiry into marble-burying as a preclinical screening paradigm of relevance for anxiety and obsessive–compulsive disorder: Mapping the way forward

  2018cites this paper
• ANIMAL STRESS MODELS IN THE STUDY OF STRESS AND STRESS RELATED PHYSIOLOGICAL AND PSYCHOLOGICAL DERANGEMENTS

  2018cites this paper
• Psychoneuroendocrinology of Resilience: An Overview

  2018cites this paper
• Brain neuropeptide S: via GPCR activation to a powerful neuromodulator of socio-emotional behaviors

  2018cites this paper
• Association between amygdala neurokinin-1 receptor availability and anxiety-related personality traits

  2018cites this paper
• Fetal alcohol exposure induces neurotoxic effects on β-endorphin neurons through microglial activation

  2018cites this paper
• Increased Anxiety and Anhedonia in Female Rats Following Exposure to Altitude

  2018cites this paper
• Pharmacological and Chemogenetic Characterization and Modulation of the Brain Neuropeptide S and Oxytocin

  2017influential citation
• Drug-induced panic attacks: Analysis of cases registered in the French pharmacovigilance database.

  2017cites this paper
• Anxiety Symptoms and Immuno-endocrine Systems from Childhood to Adolescence: Understanding Reciprocal Change over Time

  2017cites this paper
• Data-Driven Subgroups in Depression Derived from Directed Functional Connectivity Paths at Rest

  2017cites this paper
• Human anxiety remains a major unmet medical need despite decades of preclinical and clinical research

  2017cites this paper
• Pomegranate seed extract reduces ischemia induced anxiety in male rats

  2017cites this paper
• Can Anticonvulsants Help Patients With Anxiety Disorders ?

  2017cites this paper
• Transdiagnostic models of anxiety disorder: Theoretical and empirical underpinnings.

  2017cites this paper
• What Future Role Might N-Acetyl-Cysteine Have in the Treatment of Obsessive Compulsive and Grooming Disorders?: A Systematic Review

  2016cites this paper
• JNK regulation of neurogenesis, neuroplasticity and anxiety-related behaviors in mice

  2016cites this paper
• Contributions to the development and validation of fMRI-based biomarkers for drug discovery in social anxiety disorder

  2016cites this paper
• Die geschlechtsspezifische Bedeutung von Isoformen der NO-Synthase für die Ang-(1-7) modifizierte Langzeitpotenzierung in der lateralen Amygdala

  2016cites this paper
• Reward memory relieves anxiety‐related behavior through synaptic strengthening and protein kinase C in dentate gyrus

  2016cites this paper
• Anxiety in Chronic Moderate to Severe Traumatic Brain Injury: Measurement and Relation to Hippocampal Volume Loss

  2015cites this paper
• (S)-citalopram influences amygdala modulation in healthy subjects: a randomized placebo-controlled double-blind fMRI study using dynamic causal modeling

  2015cites this paper
• Effects of Oral Vitamin C Supplementation on Anxiety in Students: A Double-Blind, Randomized, Placebo-Controlled Trial.

  2015cites this paper
• Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171

  2015cites this paper
• Understanding the Pathophysiology and Management of the Anxiety Disorders

  2015influential citation
• What future role might N-acetyl-cysteine have in the treatment of Obsessive Compulsive Spectrum disorders? A systematic review

  2015cites this paper
• Chronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disorders.

  2015cites this paper
• Plasma Oxytocin Levels in Untreated Adult Obsessive-Compulsive Disorder Patients

  2015cites this paper
• Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions

  2014cites this paper
• Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic use

  2014cites this paper
• Increase of oxidation and inflammation in nervous and immune systems with aging and anxiety.

  2014cites this paper
• Lentiviral Delivery of a Vesicular Glutamate Transporter 1 (VGLUT1)-Targeting Short Hairpin RNA Vector Into the Mouse Hippocampus Impairs Cognition

  2014cites this paper
• Molecular underpinnings of anxiety regulation: Novel insights into the role of the purinergic and oxytocinergic systems within the paraventricular nucleus of the hypothalamus

  2014cites this paper
• CRHR1 links peripuberty stress with deficits in social and stress-coping behaviors.

  2014cites this paper
• Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain.

  2014cites this paper
• Functional autonomic nervous system profile in children with autism spectrum disorder

  2014cites this paper
• Chronic Non-Social Stress Affects Depressive Behaviors But Not Anxiety in Mice

  2014cites this paper
• The Hypocretin System and Psychiatric Disorders

  2014cites this paper
• Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease.

  2014cites this paper
• Protein Kinase C is Essential for Kainate‐Induced Anxiety‐Related Behavior and Glutamatergic Synapse Upregulation in Prelimbic Cortex

  2014cites this paper
• Amygdala activation and GABAergic gene expression in hippocampal sub-regions at the interplay of stress and spatial learning

  2014cites this paper
• Microelectrode Array Fabrication and Optimization for Selective Neurochemical Detection

  2013cites this paper
• Effect Of Extract of Seed Ziziphus Jujuba on Anxiety in Male Rats

  2013cites this paper
• Animal models of anxiety disorders and stress.

  2013cites this paper
• Stress, anxiety, and dendritic spines: what are the connections?

  2013cites this paper
• Anxiety and Quality of Life in ESRD

  2013cites this paper
• ngiotensin-( 1-7 ) attenuates the anxiety and depression-like ehaviors in transgenic rats with low brain angiotensinogen ucas

  2013cites this paper
• Interaction of genetic predisposition and epigenetic factors in the development of anxiety

  2013cites this paper
• ANXIETY DISORDERS : A REVIEW

  2013cites this paper
• Anxiety Disturbances in Stroke Patients

  2013cites this paper
• Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia.

  2013cites this paper
• The body in therapy : experiences of Sensorimotor Psychotherapy

  2012cites this paper
• Sex differences in anxiety during adolescence : evidence from rodents and humans

  2012cites this paper
• N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.

  2012cites this paper
• Characterization of Neuropeptide S (NPS) in view of its potential as a novel anxiolytic therapy for anxiety disorders

  2012cites this paper
• Stress and music performance anxiety

  2012cites this paper
• DISRUPTIONS IN THE REGULATION OF EXTRACELLULAR GLUTAMATE IN THE RAT CENTRAL NERVOUS SYSTEM AFTER DIFFUSE BRAIN INJURY

  2012cites this paper
• Neuropeptide Regulation of Stress-Induced Behavior

  2012cites this paper
• Deep brain stimulation for intractable psychiatric disorders.

  2012cites this paper
• 16 – Anxiety disorders

  2012cites this paper
• mGluR1,5 activation improves network asynchrony and GABAergic synapse attenuation in the amygdala: implication for anxiety-like behavior in DBA/2 mice

  2012cites this paper
• Serotonin circuits and anxiety: what can invertebrates teach us?

  2012cites this paper
• Amygdala Subregions Tied to SSRI and Placebo Response in Patients with Social Anxiety Disorder

  2012cites this paper